Stromal cells and stem cells in clinical bone regeneration
- PMID: 25560703
- PMCID: PMC4338988
- DOI: 10.1038/nrendo.2014.234
Stromal cells and stem cells in clinical bone regeneration
Abstract
Stem-cell-mediated bone repair has been used in clinical trials for the regeneration of large craniomaxillofacial defects, to slow the process of bone degeneration in patients with osteonecrosis of the femoral head and for prophylactic treatment of distal tibial fractures. Successful regenerative outcomes in these investigations have provided a solid foundation for wider use of stromal cells in skeletal repair therapy. However, employing stromal cells to facilitate or enhance bone repair is far from being adopted into clinical practice. Scientific, technical, practical and regulatory obstacles prevent the widespread therapeutic use of stromal cells. Ironically, one of the major challenges lies in the limited understanding of the mechanisms via which transplanted cells mediate regeneration. Animal models have been used to provide insight, but these models largely fail to reproduce the nuances of human diseases and bone defects. Consequently, the development of targeted approaches to optimize cell-mediated outcomes is difficult. In this Review, we highlight the successes and challenges reported in several clinical trials that involved the use of bone-marrow-derived mesenchymal or adipose-tissue-derived stromal cells. We identify several obstacles blocking the mainstream use of stromal cells to enhance skeletal repair and highlight technological innovations or areas in which novel techniques might be particularly fruitful in continuing to advance the field of skeletal regenerative medicine.
Conflict of interest statement
J.M.G. is co-founder, co-owner and Chief Scientific Officer of LaCell, a biotechnology company focusing on the clinical translation of stromal-cell and stem-cell science. The other authors declare no competing interests.
Figures
Similar articles
-
Mesenchymal stem cells for bone repair and metabolic bone diseases.Mayo Clin Proc. 2009 Oct;84(10):893-902. doi: 10.4065/84.10.893. Mayo Clin Proc. 2009. PMID: 19797778 Free PMC article. Review.
-
Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells--potential and pitfalls.Adv Drug Deliv Rev. 2011 Apr 30;63(4-5):342-51. doi: 10.1016/j.addr.2010.12.004. Epub 2010 Dec 22. Adv Drug Deliv Rev. 2011. PMID: 21184789 Review.
-
Mesenchymal cells for skeletal tissue engineering.Expert Opin Biol Ther. 2008 Jul;8(7):885-93. doi: 10.1517/14712598.8.7.885. Expert Opin Biol Ther. 2008. PMID: 18549320 Review.
-
The role of mesenchymal stem cells in bone repair and regeneration.Eur J Orthop Surg Traumatol. 2014 Apr;24(3):257-62. doi: 10.1007/s00590-013-1328-5. Epub 2013 Oct 8. Eur J Orthop Surg Traumatol. 2014. PMID: 24101189 Review.
-
Stem cell-based bone regeneration in diseased microenvironments: Challenges and solutions.Biomaterials. 2019 Mar;196:18-30. doi: 10.1016/j.biomaterials.2017.10.046. Epub 2017 Oct 30. Biomaterials. 2019. PMID: 29122279 Review.
Cited by
-
Long noncoding RNA KCNMA1-AS1 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells by activating the SMAD9 signaling pathway.Biol Direct. 2023 Nov 29;18(1):81. doi: 10.1186/s13062-023-00425-2. Biol Direct. 2023. PMID: 38017487 Free PMC article.
-
Bone marrow-derived dedifferentiated fat cells exhibit similar phenotype as bone marrow mesenchymal stem cells with high osteogenic differentiation and bone regeneration ability.J Orthop Surg Res. 2023 Mar 11;18(1):191. doi: 10.1186/s13018-023-03678-9. J Orthop Surg Res. 2023. PMID: 36906634 Free PMC article.
-
Harnessing electromagnetic fields to assist bone tissue engineering.Stem Cell Res Ther. 2023 Jan 11;14(1):7. doi: 10.1186/s13287-022-03217-z. Stem Cell Res Ther. 2023. PMID: 36631880 Free PMC article. Review.
-
Kartogenin Improves Osteogenesis of Bone Marrow Mesenchymal Stem Cells via Autophagy.Stem Cells Int. 2022 Dec 22;2022:1278921. doi: 10.1155/2022/1278921. eCollection 2022. Stem Cells Int. 2022. PMID: 36591373 Free PMC article.
-
Mesenchymal Stromal Cell-Based Bone Regeneration Therapies: From Cell Transplantation and Tissue Engineering to Therapeutic Secretomes and Extracellular Vesicles.Front Bioeng Biotechnol. 2019 Nov 27;7:352. doi: 10.3389/fbioe.2019.00352. eCollection 2019. Front Bioeng Biotechnol. 2019. PMID: 31828066 Free PMC article. Review.
References
-
- Raggatt LJ, et al. Fracture healing via periosteal callus formation requires macrophages for both initiation and progression of early endochondral ossification. Am J Pathol. 2014;184:3192–3204. - PubMed
-
- Hutton DL, Grayson WL. Stem cell-based approaches to engineering vascularized bone. Curr Opin Chem Eng. 2014;3:75–82.
-
- Neovius E, Engstrand T. Craniofacial reconstruction with bone and biomaterials: review over the last 11 years. J Plast Reconstr Aesthet Surg. 2010;63:1615–1623. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical